Kathleen Freson: αIIbβ3’s Hidden Role in Platelet Production
Kathleen Freson, Professor at KU Leuven, Chair of the International Society on Thrombosis and Haemostasis (ISTH), shared a post on LinkedIn about a recent article, she and her colleagues co-authord, published in Blood Journal, adding:
“Excited to share our latest publication in Blood, American Society of Hematology !
Glanzmann thrombasthenia (GT) has traditionally been viewed as a disorder of platelet function caused by defects in integrin αIIbβ3.
Our findings add to growing evidence that the story is more complex.
We show that αIIbβ3 deficiency is associated with impaired platelet production, driven in part by altered serine metabolism in megakaryocytes.
These results help explain the observation that several GT and all GT-like patients have low platelet counts, suggesting that αIIbβ3 is not only essential for platelet function but also plays an important role in platelet biogenesis.
This work provides new insights into the mechanisms regulating thrombopoiesis and highlights an unexpected link between integrin signaling, cellular metabolism, and platelet production.
Many thanks to all co-authors and collaborators who contributed to this study.
And especially congrats to Kato Ramaekers as this is mainly her PhD work !”
Title: Reduced platelet formation associated with serine metabolic dysregulation in integrin αIIbβ3-deficient megakaryocytes
Authors: Kato Ramaekers,My Tran,Marco Lunghi,Amy Hermans,Chantal Thys,Koenraad De Wispelaere,Ernest Turro,Christel Van Geet Van Geet, Quentin Van Thillo,Kathelijne Peerlinck,Koji Eto,Alan T. Nurden,Alessandra Balduini,Christian Andrea Di Buduo,Veerle Labarque,Kathleen Freson
Other articles featuring Kathleen Freson on Hemostasis Today.
-
Sep 6, 2026, 16:41Christina (Tina) P.: APS – How it Happens in Your Blood, the Warning Signs, and What to Do about It
-
Sep 6, 2026, 16:33Jose Angel Nicolas Avila: How Tissue Mitochondrial Activity Dictates Macrophage Pool Size
-
Sep 6, 2026, 16:23Kevin Buda: Many High-Risk PE Patients Have Contraindications to Thrombolysis
-
Sep 6, 2026, 16:16Venk Murthy: 2018 vs 2026 ACC/AHA Lipid Guidelines – A Shift From RCTs to Expert Opinion?
-
Sep 6, 2026, 16:11Silmara Montalvão: Improving Global Hemophilia Diagnostics Through Sustained External Quality Assessment
-
Sep 6, 2026, 14:50Mohamed F Doheim: Unraveling the Symphony of Stroke Management
-
Sep 6, 2026, 14:47Ahmed Bennis: E-Cigarette Use and Early Cardiovascular Risk in Young Adults
-
Sep 6, 2026, 14:46William Wallace: Iron Deficiency Can be Present Before Hemoglobin Falls and Before Anemia Appears
-
Sep 6, 2026, 14:15Listening to One Another Drives Innovation and Better Therapies in Hemophilia Care – Global Hemophilia Report